Move Towards ‘Default Disclosure’ In Revamped EU Transparency Guidance Concerns Industry

Industry calls for more balance when it comes to transparency and data protection (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Europe

More from Pathways & Standards